Granules India’s shares plummeted 16% to Rs 566 on Thursday after receiving six observations from the USFDA, including issues with equipment cleanliness and quality control procedures. Over 3 crore shares traded as investors reacted to the news.
| Subscribe To Our Free Newsletter |
